Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment

•Synthesis of degradable multiblock polymeric nanomedicines.•Cytotoxicity of combination treatments determined by combination index analysis.•Sequential addition of nanomedicines to A2780 cells has an impact on cytotoxicity.•Two nanomedicines are more cytotoxic than a nanomedicine containing both dr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2013-09, Vol.454 (1), p.435-443
Hauptverfasser: Larson, Nate, Yang, Jiyuan, Ray, Abhijit, Cheney, Darwin L., Ghandehari, Hamidreza, Kopeček, Jindřich
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Synthesis of degradable multiblock polymeric nanomedicines.•Cytotoxicity of combination treatments determined by combination index analysis.•Sequential addition of nanomedicines to A2780 cells has an impact on cytotoxicity.•Two nanomedicines are more cytotoxic than a nanomedicine containing both drugs. The synthesis, characterization, and in vitro evaluation of a combination delivery of multiblock poly(N-2-hydroxypropyl)methacrylamide (HPMA), gemcitabine (GEM) and paclitaxel (PTX) conjugates is described in this study. Multiblock copolymer conjugates of a large molecular weight (Mw>200kDa) were studied and compared to traditional, small molecular weight (Mw
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2013.06.046